Filter Search for grants
Call Navigation
Call key data
Building public trust and outreach in the life sciences
Funding Program
Horizon Europe: Cluster 1 - Health
Call number
HORIZON-HLTH-2026-01-STAYHLTH-03
deadlines
Opening
10.02.2026
Deadline
16.04.2026 17:00
Funding rate
100%
Call budget
€ 1,900,000.00
Estimated EU contribution per project
between € 1,500,000.00 and € 1,900,000.00
Link to the call
Link to the submission
Call content
short description
Life science innovations significantly contribute to peoples’ daily life and to individual and social well-being. To foster public trust, people must understand how life sciences work and how these technologies may impact people’s lives. This trust is not guaranteed. It is increasingly threatened by the rapid spread of mis- and disinformation and by insufficient outreach to and involvement of people to address their concerns and expectations. To maintain and deepen trust, especially among young people, R&I policymakers, researchers and industry players must be better equipped to engage with the public and to pursue responsible research and innovation.
Call objectives
Citizen engagement is particularly critical in areas like agriculture and food technology, where innovation intersects with health and sustainability considerations and values. Furthermore, citizen participation is key to build trust in the life sciences and ensure that they meet societal needs. By engaging citizens early on, we can ensure that research and innovation align with their values, concerns and expectations. This involves designing research and innovation processes that incorporate citizen input, such as setting research priorities, and create outcomes that are responsive to their needs.
To this end, proposals should address all the following activities:
- Provide advisory support and training to life science stakeholders, in order to upskill them in science communication and risk communication.
- Produce, publish and advertise to the relevant actors, guidance to engage citizens upstream in the development, co-production, and co-design of life sciences innovation.
- Produce, publish, and advertise to the relevant public an accessible repository of tools for life science stakeholders on risk communication.
- Design and run community engagement activities in the life sciences, in partnership with relevant local actors, such as science museums, R&I organisations, and/or community organisations.
Regarding advisory support and training, proposals should present how they will engage bilaterally with life science stakeholders to advise them and train them on science communication and risk communication in the life sciences. The proposal selected for funding should also establish links with the European Competence Centre for Science Communication currently being created by the COALESCE project and expected to be launched in 2027.
Regarding engagement of citizens in the development, co-production and co-design of life sciences innovations, proposals should focus on advising and training life science actors in deliberative citizen participation and co-design with citizens, including tools that allow discussions about values and ethical considerations of innovations in this sector. Proposals should set out the ways in which they will support life science actors to involve citizens in co-design, and also set out how they will evaluate the impact of the citizen engagement activities that they have supported. The consortium selected for funding is encouraged to use the tools and methods developed under previous research and tailor them to the life sciences.
Regarding the repository of tools and support for risk communication, such tools already exist and have been developed, notably the EU funded projects listed in the CORDIS Results Pack “Science communication: Empowering citizens in the public discussion of science”, the CORDIS Results Pack “Ethics and integrity: Building bridges for trust and excellence in research and innovation” and the World Health Organization (WHO) guidelines for emergency risk communication. Proposals should present what tools they will gather, how they will publish them, and what publicity and outreach they will conduct to raise awareness of this repository among the relevant life science actors (policymakers, researchers, industry, civil society organisations), tailoring tools and trainings to the life sciences. Proposals should present a long-term strategy for how the repository of tools will continue to be accessible beyond the lifecycle of this Coordination and Support Action (CSA).
Regarding community engagement activities, proposals should experiment with new and engaging formats across the programmed activities. Proposals should promote both science education, and multiple forms of public engagement with science, focusing on the life sciences. Proposals should focus on any areas within the life sciences, but at least one community engagement activity should focus on agriculture and food technology. The consortium selected for funding is encouraged to make use of findings and tools for stakeholder engagement developed by other Horizon Europe projects, including projects funded under topic HORIZON-CL6-2023-GOVERNANCE-01-6: “Co-creation and trust-building measures for biotechnology and bio-based innovation systems”. The consortium selected for funding is also encouraged to establish links with the projects funded under topic HORIZON-WIDERA-2026-07-ERA-05: “Pillar III: Fostering citizen engagement for more responsible and democratic R&I”, that will develop tools and guidelines on public engagement in R&I, and to tailor these tools and guidelines to applications in the life sciences. Proposals should explain how they will partner with relevant local actors, such as science museums, R&I organisations, and/or community organisations, to run innovative community engagement activities on the life sciences.
Proposals may consider involving the European Commission's Joint Research Centre (JRC) to participate in the advisory board of the consortium selected for funding, notably to benefit from the expertise of the JRC's Competence Centre on Participatory and Deliberative Democracy, regarding the engagement of citizens in the design of life sciences innovations and community engagement activities. Any such collaboration should be established after the proposal’s approval.
read more
Expected results
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Staying healthy in a rapidly changing society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- Strengthened capacity of life sciences actors in science communication, risk communication, public outreach, and citizen engagement.
- Strengthened awareness of risks and benefits of life sciences by the public, by showcasing the latest Research and Innovation (R&I) developments in the life sciences, and their societal impact.
- New and innovative approaches developed to engage the public in R&I activities in the life sciences, with an emphasis on inclusive and participatory approaches, involving relevant stakeholders (e.g. researchers, research funders, policymakers, publishers, civil society organisations, business, and citizens).
read more
Eligibility Criteria
Regions / countries for funding
Faeroes (Føroyar / Færøerne), Iceland (Ísland), Israel (ישראל / إِسْرَائِيل), Kosovo (Kosova/Kosovë / Косово), Liechtenstein, Norway (Norge), Switzerland (Schweiz/Suisse/Svizzera), Tunisia (تونس /Tūnis), United Kingdom
eligible entities
EU Body, Education and training institution, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), Other, Private institution, incl. private company (private for profit), Public Body (national, regional and local; incl. EGTCs), Research Institution incl. University, Small and medium-sized enterprise (SME)
Mandatory partnership
Yes
Project Partnership
To be eligible for funding, applicants must be established in one of the following countries:
- the Member States of the European Union, including their outermost regions: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden.
- the Overseas Countries and Territories (OCTs) linked to the Member States: Aruba (NL), Bonaire (NL), Curação (NL), French Polynesia (FR), French Southern and Antarctic Territories (FR), Greenland (DK), New Caledonia (FR), Saba (NL), Saint Barthélemy (FR), Sint Eustatius (NL), Sint Maarten (NL), St. Pierre and Miquelon (FR), Wallis and Futuna Islands (FR).
- countries associated to Horizon Europe; Albania, Arab Republic of Egypt, Armenia, Bosnia and Herzegovina, Canada, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Norway, Republic of Korea, Serbia, Switzerland, Tunisia, Türkiye, Ukraine, United Kingdom. Other third countries may become associated to Horizon Europe during the programme. For the purposes of the eligibility conditions, applicants established in other third countries negotiating association to Horizon Europe will be treated as entities established in an Associated Country, if the Horizon Europe association agreement with the third country concerned applies at the time of signature of the grant agreement.
- In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding.
Legal entities which are established in countries not listed above will be eligible for funding if provided for in the specific call/topic conditions, or if their participation is considered essential for implementing the action by the granting authority.
Any legal entity, regardless of its place of establishment, including legal entities from non associated third countries or international organisations (including international European research organisations) is eligible to participate (whether it is eligible for funding or not), provided that the conditions laid down in the Horizon Europe Regulation have been met, along with any other conditions laid down in the specific call/topic.
A ‘legal entity’ means any natural or legal person created and recognised as such under national law, EU law or international law, which has legal personality and which may, acting in its own name, exercise rights and be subject to obligations, or an entity without legal personality.
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:
- at least one independent legal entity established in a Member State; and
- at least two other independent legal entities, each established in different Member States or Associated Countries.
As affiliated entities do not sign the grant agreement, they do not count towards the minimum eligibility criteria for consortium composition (if any).
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding. Coordinators of projects must be legal entities established in an EU Member State or Associated Country.
The Joint Research Centre (JRC) may participate as member of the consortium selected for funding as a beneficiary with zero funding, or as an associated partner. The JRC will not participate in the preparation and submission of the proposal - see General Annex B.
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
other eligibility criteria
Specific cases
Affiliated entities — Affiliated entities (i.e. entities with a legal or capital link to a beneficiary which participate in the action with similar rights and obligations to the beneficiaries, but which do not sign the grant agreement and therefore do not become beneficiaries themselves) are allowed, if they are eligible for participation and funding.
Associated partners — Associated partners (i.e. entities which participate in the action without signing the grant agreement, and without the right to charge costs or claim contributions) are allowed, subject to any specific call/topic conditions.
Entities without legal personality — Entities which do not have legal personality under their national law may exceptionally participate, provided that their representatives have the capacity to undertake legal obligations on their behalf, and offer guarantees to protect the EU’s financial interests equivalent to those offered by legal persons.
EU bodies — Legal entities created under EU law including decentralised agencies may be part of the consortium, unless provided for otherwise in their basic act.
Joint Research Centre (‘JRC’) — Where provided for in the specific call/topic conditions, applicants may include in their proposals the possible contribution of the JRC, but the JRC will not participate in the preparation and submission of the proposal. Applicants will indicate the contribution that the JRC could bring to the project based on the scope of the topic text. After the evaluation process, the JRC and the consortium selected for funding may come to an agreement on the specific terms of the participation of the JRC. If an agreement is found, the JRC may accede to the grant agreement as beneficiary requesting zero funding or participate as an associated partner, and would accede to the consortium as a member.
Associations and interest groupings — Entities composed of members (e.g. European research infrastructure consortia (ERICs)) may participate as ‘sole beneficiaries’ or ‘beneficiaries without legal personality’. However, if the action is in practice implemented by the individual members, those members should also participate either as beneficiaries or as affiliated entities (otherwise their costs will NOT be eligible).
EU restrictive measures — Entities subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU) as well as Article 75 TFEU, are not eligible to participate in any capacity, including as beneficiaries, affiliated entities, associated partners, third parties giving in-kind contributions, subcontractors or recipients of financial support to third parties (if any).
Legal entities established in Russia, Belarus, or in non-government controlled territories of Ukraine — Given the illegal invasion of Ukraine by Russia and the involvement of Belarus, there is currently no appropriate context allowing the implementation of the actions foreseen in this programme with legal entities established in Russia, Belarus, or in non-government controlled territories of Ukraine. Therefore, even where such entities are not subject to EU restrictive measures, such legal entities are not eligible to participate in any capacity. This includes participation as beneficiaries, affiliated entities, associated partners, third parties giving in-kind contributions, subcontractors or recipients of financial support to third parties (if any). Exceptions may be granted on a case-by-case basis for justified reasons.
With specific regard to measures addressed to Russia, following the adoption of the Council Regulation (EU) 2024/1745 of 24 June 2024 (amending Council Regulation (EU) No 833/2014 of 31 July 2014) concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine, legal entities established outside Russia whose proprietary rights are directly or indirectly owned for more than 50% by a legal person, entity or body established in Russia are also not eligible to participate in any capacity.
Measures for the protection of the Union budget against breaches of the principles of the rule of law in Hungary — Following the Council Implementing Decision (EU) 2022/2506, as of 16 December 2022, no legal commitments can be entered into with Hungarian public interest trusts established under the Hungarian Act IX of 2021 or any entity they maintain. Affected entities may continue to apply to calls for proposals and can participate without receiving EU funding, as associated partners, if allowed by the call conditions. However, as long as the Council measures are not lifted, such entities are not eligible to participate in any funded role (beneficiaries, affiliated entities, subcontractors, recipients of financial support to third parties, etc.). In the case of multi-beneficiary grant calls, applicants will be invited to remove or replace that entity in any funded role and/or to change its status into associated partner. Tasks and budget may be redistributed accordingly.
Additional information
Topics
Relevance for EU Macro-Region
EUSDR - EU Strategy for the Danube Region, EUSBSR - EU Strategy for the Baltic Sea Region, EUSALP - EU Strategy for the Alpine Space, EUSAIR - EU Strategy for the Adriatic and Ionian Region
UN Sustainable Development Goals (UN-SDGs)
Additional Information
Applications must be submitted electronically via the Funders & Tenders Portal electronic submission system (accessible via the topic page in the Search Funding & Tenders section). Paper submissions are NOT possible.
Applications must be submitted using the forms provided inside the electronic submission system (not the templates available on the topic page, which are only for information). The structure and presentation must correspond to the instructions given in the forms.
Applications must be complete and contain all parts and mandatory annexes and supporting documents.
Applications must include a plan for the exploitation and dissemination of results including communication activities, unless provided otherwise in the specific call/topic conditions. The plan is not required for applications at the first stage of two-stage procedures. If the expected exploitation of the results entails developing, creating, manufacturing and marketing a product or process, or in creating and providing a service, the plan must include a strategy for such exploitation. If the plan provides for exploitation of the results primarily in non-associated third countries, the applicants must explain how that exploitation is to be considered in the EU’s interest.
The application form will have two parts:
- Part A (to be filled in directly online) contains administrative information about the applicant organisations (future coordinator and beneficiaries and affiliated entities), the summarised budget for the proposal and call-specific questions;
- Part B (to be downloaded from the Portal submission system, completed and then assembled and re-uploaded as a PDF in the system) contains the technical description of the project.
Annexes and supporting documents will be directly available in the submission system and must be uploaded as PDF files (or other formats allowed by the system).
The limit for a full application (Part B) is 28 pages.
Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025).
The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold will be 12.
Call documents
Horizon Europe Work Programme 2026-2027 Cluster 1 - HealthHorizon Europe Work Programme 2026-2027 Cluster 1 - Health(1700kB)
Contact
To see more information about this call, you can register for free here
or log in with an existing account.
Log in
Register now

